AllianceBernstein’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.77B | Sell |
3,910,786
-585,696
| -13% | -$273M | 0.57% | 25 |
|
|
2025
Q4 | $2.04B | Sell |
4,496,482
-26,104
| -0.6% | -$11.3M | 0.64% | 22 |
|
|
2025
Q3 | $1.77B | Buy |
4,522,586
+144,266
| +3% | +$60.3M | 0.56% | 28 |
|
|
2025
Q2 | $1.95B | Buy |
4,378,320
+424,808
| +11% | +$196M | 0.64% | 25 |
|
|
2025
Q1 | $1.92B | Buy |
3,953,512
+33,492
| +0.9% | +$15.6M | 0.69% | 21 |
|
|
2024
Q4 | $1.58B | Sell |
3,920,020
-3,452,747
| -47% | -$1.6B | 0.54% | 33 |
|
|
2024
Q3 | $3.43B | Buy |
7,372,767
+151,695
| +2% | +$72.9M | 1.15% | 14 |
|
|
2024
Q2 | $3.38B | Buy |
7,221,072
+123,791
| +2% | +$53.7M | 1.18% | 11 |
|
|
2024
Q1 | $2.97B | Buy |
7,097,281
+57,543
| +0.8% | +$24.3M | 1.05% | 11 |
|
|
2023
Q4 | $2.86B | Sell |
7,039,738
-486,718
| -6% | -$180M | 1.1% | 11 |
|
|
2023
Q3 | $2.62B | Sell |
7,526,456
-8,578
| -0.1% | -$3M | 1.11% | 9 |
|
|
2023
Q2 | $2.65B | Sell |
7,535,034
-838,239
| -10% | -$282M | 1.08% | 9 |
|
|
2023
Q1 | $2.64B | Sell |
8,373,273
-696,307
| -8% | -$209M | 1.13% | 9 |
|
|
2022
Q4 | $2.62B | Sell |
9,069,580
-75,936
| -0.8% | -$23.1M | 1.18% | 9 |
|
|
2022
Q3 | $2.65B | Sell |
9,145,516
-154,714
| -2% | -$44.5M | 1.28% | 9 |
|
|
2022
Q2 | $2.62B | Sell |
9,300,230
-1,254,811
| -12% | -$336M | 1.2% | 10 |
|
|
2022
Q1 | $2.75B | Buy |
10,555,041
+111,270
| +1% | +$26.4M | 1.06% | 14 |
|
|
2021
Q4 | $2.29B | Buy |
10,443,771
+1,374,923
| +15% | +$267M | 0.81% | 16 |
|
|
2021
Q3 | $1.64B | Buy |
9,068,848
+2,690,416
| +42% | +$525M | 0.65% | 21 |
|
|
2021
Q2 | $1.29B | Sell |
6,378,432
-1,480,175
| -19% | -$310M | 0.52% | 28 |
|
|
2021
Q1 | $1.69B | Sell |
7,858,607
-83,154
| -1% | -$18.3M | 0.74% | 16 |
|
|
2020
Q4 | $1.88B | Buy |
7,941,761
+1,342,210
| +20% | +$308M | 0.89% | 14 |
|
|
2020
Q3 | $1.8B | Buy |
6,599,551
+813,580
| +14% | +$224M | 0.97% | 12 |
|
|
2020
Q2 | $1.68B | Sell |
5,785,971
-407,880
| -7% | -$111M | 0.99% | 12 |
|
|
2020
Q1 | $1.47B | Sell |
6,193,851
-167,782
| -3% | -$38.5M | 1.06% | 11 |
|
|
2019
Q4 | $1.39B | Buy |
6,361,633
+580,418
| +10% | +$117M | 0.79% | 16 |
|
|
2019
Q3 | $979M | Buy |
5,781,215
+686,812
| +13% | +$122M | 0.61% | 27 |
|
|
2019
Q2 | $934M | Buy |
5,094,403
+1,777,171
| +54% | +$311M | 0.58% | 33 |
|
|
2019
Q1 | $610M | Buy |
3,317,232
+386,502
| +13% | +$71.4M | 0.4% | 56 |
|
|
2018
Q4 | $486M | Buy |
2,930,730
+2,394,289
| +446% | +$415M | 0.36% | 61 |
|
|
2018
Q3 | $103M | Buy |
536,441
+40,336
| +8% | +$7.18M | 0.07% | 298 |
|
|
2018
Q2 | $84.3M | Buy |
496,105
+29,847
| +6% | +$4.63M | 0.06% | 352 |
|
|
2018
Q1 | $76M | Sell |
466,258
-5,020
| -1% | -$820K | 0.05% | 366 |
|
|
2017
Q4 | $70.6M | Sell |
471,278
-7,016
| -1% | -$1.04M | 0.05% | 404 |
|
|
2017
Q3 | $72.7M | Buy |
478,294
+34,642
| +8% | +$5.21M | 0.05% | 382 |
|
|
2017
Q2 | $57.2M | Buy |
443,652
+4,164
| +0.9% | +$501K | 0.04% | 445 |
|
|
2017
Q1 | $48.1M | Sell |
439,488
-14,469
| -3% | -$1.27M | 0.04% | 484 |
|
|
2016
Q4 | $33.4M | Sell |
453,957
-12,092
| -3% | -$984K | 0.03% | 564 |
|
|
2016
Q3 | $40.6M | Buy |
466,049
+1,358
| +0.3% | +$128K | 0.03% | 505 |
|
|
2016
Q2 | $40M | Buy |
464,691
+7,491
| +2% | +$647K | 0.03% | 480 |
|
|
2016
Q1 | $36.3M | Sell |
457,200
-3,775
| -0.8% | -$341K | 0.03% | 511 |
|
|
2015
Q4 | $58M | Sell |
460,975
-1,999
| -0.4% | -$241K | 0.05% | 407 |
|
|
2015
Q3 | $48.2M | Sell |
462,974
-5,942
| -1% | -$763K | 0.04% | 445 |
|
|
2015
Q2 | $57.9M | Sell |
468,916
-92,272
| -16% | -$11.6M | 0.05% | 434 |
|
|
2015
Q1 | $66.2M | Sell |
561,188
-71,004
| -11% | -$8.51M | 0.05% | 391 |
|
|
2014
Q4 | $75.1M | Sell |
632,192
-68,841
| -10% | -$7.75M | 0.06% | 336 |
|
|
2014
Q3 | $78.7M | Sell |
701,033
-677,587
| -49% | -$64.5M | 0.07% | 328 |
|
|
2014
Q2 | $131M | Sell |
1,378,620
-1,266,303
| -48% | -$88.8M | 0.11% | 208 |
|
|
2014
Q1 | $187M | Buy |
2,644,923
+227,282
| +9% | +$18M | 0.16% | 146 |
|
|
2013
Q4 | $180M | Buy |
2,417,641
+428,030
| +22% | +$29.8M | 0.16% | 149 |
|
|
2013
Q3 | $151M | Sell |
1,989,611
-491,244
| -20% | -$39.1M | 0.15% | 151 |
|
|
2013
Q2 | $198M | Buy |
+2,480,855
| New | +$183M | 0.21% | 111 |
|
Other funds holding VRTX
VCM
VPM
AllianceBernstein's VRTX Position: Q1 2026 in Review
AllianceBernstein reduced its Vertex Pharmaceuticals (VRTX) stake by 13% in Q1 2026, selling an estimated $273M and leaving 3,910,786 shares worth $1.77B. The position accounts for 0.57% of the portfolio, ranked #25.
AllianceBernstein first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.43B in Q3 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- AllianceBernstein held 3,910,786 shares of Vertex Pharmaceuticals worth $1.77B as of Q1 2026.
- AllianceBernstein sold 585,696 Vertex Pharmaceuticals shares in Q1 2026, an estimated $273M.
- Vertex Pharmaceuticals made up 0.57% of AllianceBernstein's portfolio in Q1 2026, its #25 holding.
- AllianceBernstein first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Vertex Pharmaceuticals position peaked at $3.43B in Q3 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.